XORTX Therapeutics Inc's total assets for Q3 2024 were C$3.85M, a decrease of -19.77% from the previous quarter. TSE:XRTX total liabilities were C$1.72M for the fiscal quarter, a -18.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.